disease 866 words KG: ent-dise-530917aa
Contents

Sporadic ALS Initiation Mechanisms

Disease Info
TDP-43 proteinopathyFound in ~95% of ALS cases (including sporadic), TDP-43 is an RNA-binding protein that forms cytoplasmic aggregates in affected neurons[@neumann2006]
FUS mutationsFUS (Fused in Sarcoma) is another RNA-binding protein mutated in some familial and rare sporadic ALS cases[@kwiatkowski2009]
Alternative splicing disruptionsMultiple ALS-linked genes regulate RNA splicing, suggesting this pathway may be a common vulnerability[@ling2013]
Neurofilament aggregationAbnormal neurofilament accumulation is a hallmark of ALS motor neurons[@julien1998]
Axonal transport defectsMutations in genes involved in axonal transport (e.g., DCTN1) are linked to ALS
Energy failureMitochondrial dysfunction leads to ATP depletion in motor neurons
Oxidative stressMitochondrial ROS production increases in ALS
Calcium bufferingImpaired mitochondrial calcium handling exacerbates excitotoxicity[@cozzolino2012]
Microglial activationPro-inflammatory microglia are abundant in ALS spinal cord
AstrogliosisReactive astrocytes surround motor neurons
Peripheral immune involvementT cells and other immune cells infiltrate the CNS
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (9)

Phase-Separated Organelle Targeting
Score: 0.73
Stress Granule Phase Separation Modulators
Score: 0.72
Cross-Seeding Prevention Strategy
Score: 0.69
RNA Granule Nucleation Site Modulation
Score: 0.66
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.62
Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.55
Cryptic Exon Silencing Restoration
Score: 0.53
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.47

Related Analyses (30)

RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (22)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.